Sponsored by:

Business in the Burbs

Movers, shakers and newsmakers

Acorda resubmits drug application


Acorda Therapeutics Inc. of Hawthorne has resubmitted an application to market Fampridine-SR, a drug that would help people with multiple sclerosis walk.

The company received word from the U.S. Food and Drug Administration March 30 that its first application was lacking information and could not be accepted for review. Acorda shares dropped $5.09, or 20.44 percent, to close at $19.81 that day.

The company said it resubmitted the application after discussions with the FDA and believes it has made the changes in the application that the agency wanted.

Acorda shares rose $3.78, or 20.6 percent this morning and were trading at $22.12 at 9:47 a.m.

This entry was posted on Thursday, April 23rd, 2009 at 9:05 am by Allan Drury. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical



About this blog
Business in the Burbs is our online news blog about businesses based or operating in the Lower Hudson Valley. Visitors here will also find items of interest to consumers in the region. Most contributions are from business reporters and editors covering Westchester, Rockland and Putnam counties.


Get blog updates via email:

About the Authors


Other recent entries


Monthly Archives